Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study.

Cem OnalEzgi OymakOzan Cem GulerBurak TilkiGuler YavasPervin HurmuzCagdas YavasGokhan Ozyigit

Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2022)

We demonstrated that SBRT in combination with TKIs is an effective and safe treatment option for RCC patients with ≤ 5 metastases. However, distant metastasis was observed in 60% of the patients, indicating that distant disease control still has room for improvement.

Keyphrases

renal cell carcinoma
end stage renal disease
lymph node
ejection fraction
newly diagnosed
early stage
prognostic factors
peritoneal dialysis
squamous cell carcinoma
radiation induced
combination therapy
patient reported